Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2004-09-17
2010-06-01
Strzelecka, Teresa E (Department: 1637)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023200, C536S023400, C536S023700, C435S320100
Reexamination Certificate
active
07728118
ABSTRACT:
A method to prepare synthetic nucleic acid molecules having reduced inappropriate or unintended transcriptional characteristics when expressed in a particular host cell.
REFERENCES:
patent: 4412001 (1983-10-01), Baldwin et al.
patent: 4503142 (1985-03-01), Berman et al.
patent: 4581335 (1986-04-01), Baldwin
patent: 4968613 (1990-11-01), Masuda et al.
patent: 5096825 (1992-03-01), Barr et al.
patent: 5168062 (1992-12-01), Stinski
patent: 5182202 (1993-01-01), Kajiyama et al.
patent: 5196524 (1993-03-01), Gustafson et al.
patent: 5219737 (1993-06-01), Kajiyama et al.
patent: 5221623 (1993-06-01), Legocki et al.
patent: 5229285 (1993-07-01), Kajiyama et al.
patent: 5283179 (1994-02-01), Wood
patent: 5292658 (1994-03-01), Cormier et al.
patent: 5330906 (1994-07-01), Kajiyama et al.
patent: 5352598 (1994-10-01), Kajiyama et al.
patent: 5418155 (1995-05-01), Cormier et al.
patent: 5567862 (1996-10-01), Adang et al.
patent: 5583024 (1996-12-01), McElroy et al.
patent: 5604123 (1997-02-01), Kazami et al.
patent: 5641641 (1997-06-01), Wood
patent: 5650289 (1997-07-01), Wood
patent: 5670356 (1997-09-01), Sherf et al.
patent: 5674713 (1997-10-01), McElroy et al.
patent: 5700673 (1997-12-01), McElroy et al.
patent: 5744320 (1998-04-01), Sherf et al.
patent: 5786464 (1998-07-01), Seed
patent: 5795737 (1998-08-01), Seed et al.
patent: 5814471 (1998-09-01), Wood
patent: 5874304 (1999-02-01), Zolotukhin et al.
patent: 5952547 (1999-09-01), Cornelissen et al.
patent: 5968750 (1999-10-01), Zolotukhin et al.
patent: 5976796 (1999-11-01), Szalay et al.
patent: 6020192 (2000-02-01), Muzyczka et al.
patent: 6074859 (2000-06-01), Hirokawa et al.
patent: 6114148 (2000-09-01), Seed et al.
patent: 6130313 (2000-10-01), Li et al.
patent: 6169232 (2001-01-01), Hey et al.
patent: 6306600 (2001-10-01), Kain et al.
patent: 6602677 (2003-08-01), Wood et al.
patent: 6700038 (2004-03-01), Dasgputa et al.
patent: 6878531 (2005-04-01), Seyfang
patent: 2002/0100076 (2002-07-01), Garcon et al.
patent: 2003/0157643 (2003-08-01), Almond et al.
patent: 2006/0127988 (2006-06-01), Wood et al.
patent: 2008/0070299 (2008-03-01), Wood et al.
patent: 2008/0090291 (2008-04-01), Wood et al.
patent: 2009/0191622 (2009-07-01), Almond et al.
patent: 0337349 (1989-10-01), None
patent: 0364707 (1990-04-01), None
patent: 0524448 (1993-01-01), None
patent: 0353464 (1993-10-01), None
patent: 08-510837 (1996-11-01), None
patent: 2000-503536 (2000-03-01), None
patent: WO-90/01542 (1990-02-01), None
patent: WO-91/16432 (1991-10-01), None
patent: WO-92/15673 (1992-09-01), None
patent: WO-95/18853 (1995-07-01), None
patent: WO-9518853 (1995-07-01), None
patent: WO-95/25798 (1995-09-01), None
patent: WO-96/22376 (1996-07-01), None
patent: WO-97/08320 (1997-03-01), None
patent: WO-97/26333 (1997-07-01), None
patent: WO-97/26366 (1997-07-01), None
patent: WO-97/47358 (1997-12-01), None
patent: WO-99/14336 (1999-03-01), None
patent: WO-01/23541 (2001-04-01), None
patent: WO-01/27150 (2001-04-01), None
patent: WO-02/16944 (2002-02-01), None
patent: WO-02016944 (2002-02-01), None
patent: WO-02090535 (2002-11-01), None
patent: WO-2004/025264 (2004-03-01), None
patent: WO-2004/042010 (2004-05-01), None
patent: WO-2006/034061 (2006-03-01), None
GenBank Accession No. AF081957.1, “Synthetic construct aminoglycoside 3′-phosphotransferase mutant (mNeo) gene, complete cds”, Aug. 1999.
GenBank Accession No. U19276.1, “Cloning vector pGFP-1 green fluorescent protein, complete cds”, Jul. 1995.
CloneTech Catalog, p. 96 (1996/97).
CloneTech docoment PT2038-5, p. 1-2 (1996/97).
GenBank Accession No. AAD50549, “Aminoglycoside 3′-phosphotransferase mutant [synthetic construct].” Aug. 1999.
GenBank Accession No. AAA69543, “Neomycin phosphotransferase” Jul. 1995.
Wells, K.D. et al., “Codon optimization, genetic insulation, and an rtTA reporter improve performance of the tetracycline swittch”, Transgenic Research, vol. 8, p. 371-381 (1999).
Shim, J. et al., “Canonical 3′-deoxyribonucleotides as a chain terminator for HCV NS5B RNA-dependent RNA polymerase”, Antiviral Research, vol. 58, pp. 243-251 (May 2003).
BIOBASE, www.gene-regulation.com/pub/databases/html; printed Jul. 31, 2007.
Leclerc, G.M., Biotechniques, vol. 29, pp. 590, 591, 594, 596, 598, 600, 601 (2000).
“Cloning Vector pGL3—Control”,NCBI Sequence Accession No. U47296, 4 pgs.
“Cloning Vector psiSTRIKE Puromycin, Complete Sequence”,NCBI Sequence Accession No. AY497507, 3 pgs.
“Sequence of pcdna3.1/Hygro”, http://www.invitrogen.com/content/sfs/vectors/pcdna3.1hygro—seq.txt, 2 pgs.
“Sequence 1 from Patent WO9529245”,NCBI Sequence Accession No. A47120, 2 pgs.
Aota, S., “Codon Usage Tabulated from the GenBank Genetic Sequence Data”,Nucleic Acids Research, 16(Supplement), (1988), r315-r402.
Bachmair, A., “In vivo Half-Life of a Protein is a Function of its Amino Terminal Residue”,Science, 234(4773), (1986), 179-186.
Batt, D. B., “Polyadenylation and Transcription Termination in Gene Constructs Containing Multiple Tandem Polyadenylation Signals”,Nucleic Acids Research, 22(14), (Jul. 15, 1994), 2811-2816.
Benzakour, O., “Evaluation of the Use of the Luciferase-Reporter-Gene System for Gene-Regulation Studies Involving Cyclic AMP-Elevating Agents”,The Biochemical Journal, 309 (Pt 2), (1995), 385-387.
Bernardi, G., “Codon Usage and Genome Composition”,Journal of Moleular Biology, 22(4), (1985),363-365.
Bonin, A. L., “Photinus pyralisluciferase: Vectors that Contain a ModifiedlucCoding Sequence Allowing Convenient Transfer into Other Systems”,Gene, 141(1), (1994),75-77.
Bronstein, I., “Chemiluminescent and Bioluminescent Reporter Gene Assays”,Analytical Biochemistry219(2), (1994), 169-181.
Bulmer, M , “Codon Usage and Secondary Structure of MS2 Phage RNA”,Nucleic Acids Res., 17(5), (1989), 1839-1843.
Bulmer, M , “Coevolution of Codon Usage and Transfer RNA Abundance”,Nature, 325(6106), (1987), 728-730.
Chen, H., “Gene Transfer and Expression in Oligodendrocytes Under the Control of Myelin Basic Protein Transcriptional Control Region Mediated by Adeno-Associated Virus”,Gene Therapy, 5(1), (1998), 50-58.
Coker, G T., “8-Br-cAMP Inhibits the Transient Expression of Firefly Luciferase”,FEBS Letters, 249, (1989), 183-185.
De Wet, J. R., “Cloning of Firefly Luciferase cDNA and the Expression of Active Luciferase inEscherichia coli”, Proc. Natl. Acad. Sci. USA, 82(23), (1985), 7870-7873.
De Wet, J. R., “Firefly Luciferase Gene: Structure and Expression in Mammalian Cells”,Molecular and Cellular Biology, 7(2), (1987), 725-737.
Dean, C., “mRNA Transcripts of Several Plant Genes are Polyadenylated at Multiple Sites in vivo”,Nucleic Acids Research, vol. 14(5), (1986), 2229-2240.
Dementieva, E. I., “Physicochemical Properties of RecombinantLuciola mingrelicaLuciferase and its Mutant Forms”,Biochemistry, 61(1), (1996), 115-119.
Faisst, S., “Compilation of Vertebrate-Encoded Transcription Factors”,Nucleic Acids Research, 20(1), (Jan. 11, 1992), 3-26.
Ferbitz, L., “A Synthetic Gene Coding for Renilla luciferase is a versatile expression marker in green algae”,NCBI Sequence Accession No. AAF93166(Aug. 8, 2000), 1 pg.
Fiers, W , “On Codon Usage (letter)”,Nature, 277(5694), (1979), 328.
Fleer, R., “High-Level Secretion of Correctly Processed Recombinant Human Interleukin-1β inKluyveromyces lactis”, Gene, 107(2), (1991), 285-295.
Fuerst, T. R., “Structure and Stability of mRNA Synthesized by Vaccinia Virus-Encoded Bacteriophage T7 RNA Polymerase in Mammalian Cells—Importance of the 5′ untranslated leader”,Journal of Molecular Biology, 206, (1989), 333-348.
Gould, S. J., “A Conserved Tripeptide Sorts Proteins to Peroxisomes”,The Journal of Cell Biolo
Almond Brian
Fan Frank
Paguio Aileen
Wood Keith V.
Wood Monika G.
Michael & Best & Friedrich LLP
Promega Corporation
Strzelecka Teresa E
LandOfFree
Synthetic nucleic acid molecule compositions and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic nucleic acid molecule compositions and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic nucleic acid molecule compositions and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4248293